February 15, 2024 — Abbott announced that the Circulatory System Devices Panel of the Medical Devices Advisory Committee ...
February 14, 2024 — The American College of Cardiology’s newest registry offers data-driven insights on cardiac ...
February 14, 2024 — Efemoral Medical, developer of advanced interventional bioresorbable therapies, today announced that ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
February 14, 2024 — The replacement of regular salt with a salt substitute can reduce incidences of hypertension, or ...
February 13, 2024 — Pediatric heart transplantation has long been hailed as a life-saving intervention for children ...
February 13, 2024 — RapidAI, the global leader in developing Artificial Intelligence (AI) and clinical workflow ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
February 13, 2024 — Butterfly Network, Inc., a digital health company transforming care through the power of portable ...
February 13, 2024 — Cleerly, a digital healthcare company focused on artificial intelligence (AI)-driven heart disease ...
February 12, 2024 — Sensome, a company pioneering the connected medical device revolution with the world’s smallest ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
February 12, 2024 — BIOTRONIK, a leader in implantable medical device technology, announced today they will solely ...
February 12, 2024 — VST Bio Corp. a leader in the development of innovative biologics to treat acute and chronic ...
February 12, 2024 — According to the American Journal of Roentgenology (AJR), free-breathing cine-deep learning (DL) may ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
February 12, 2023 — A team at Allina Health Minneapolis Heart Institute at Abbott Northwestern Hospital has successfully ...
February 9, 2024 — Injection of a substance to block an artery feeding the dura (protective sack around the brain) — ...
February 9, 2024 — MIVI Neuroscience, Inc. announced the primary endpoint results of its EvaQ Trial, a prospective ...